Final Results of a Phase I/II Trial of Carfilzomib plus R-CHOP for Frontline Treatment of Patients with Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL)

被引：0
|
作者：
Hill, Brian T. [1 ]
Torka, Pallawi [2 ]
Hernandez-Ilizaliturri, Francisco J. [3 ]
Dean, Robert M. [4 ]
Jagadeesh, Deepa [1 ]
Karamlou, Kasra [1 ]
Fu, Chieh-Lin [5 ]
Winter, Allison [4 ]
Krauspe, Ethan [1 ]
Zhou, Jonathan [1 ]
Brooks, Taylor R. [1 ]
Kacar, Merve [6 ]
Tomlinson, Ben K. [7 ]
Cooper, Brenda W. [7 ]
Li, Hong [8 ]
Jia, Xuefei [1 ]
Chen, Yanwen [1 ]
Thomas, Jenna [1 ]
Caimi, Paolo F. [4 ]
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Mem Sloan Kettering Canc Ctr, Lymphoma Serv, Dept Med, Montvale, NJ USA
[3] SUNY Buffalo, Jacobs Sch Med & Biomed Sci, Roswell Park Comprehens Canc Ctr, Buffalo, NY USA
[4] Cleveland Clin, Taussig Canc Inst, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
[5] Cleveland Clin Florida, Maroone Canc Ctr, Weston, FL USA
[6] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[7] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA
[8] Cleveland Clin, Dept Biostat & Quantitat Hlth Sci, Cleveland, OH 44106 USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-173943
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Phase I Trial of Carfilzomib plus R-CHOP (CarR-CHOP) for Frontline Treatment of Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
    Hill, Brian T.
    Dean, Robert M.
    Jagadeesh, Deepa
    Garcia, Alex V. Mejia
    Pohlman, Brad
    Winter, Allison M.
    Krauspe, Ethan
    Collier, Patrick
    D'Andrea, Christopher
    Morrison, Ashley
    Lehmann, Sarah
    Tomlinson, Benjamin K.
    Cooper, Brenda
    de Lima, Marcos
    Ondrejka, Sarah L.
    Hsi, Eric D.
    Caimi, Paolo
    BLOOD, 2018, 132
  • [2] TREATMENT WITH LENALIDOMIDE + R-CHOP (R2-CHOP) OF DIFFUSE LYMPHOMA OF LARGE NON-GERMINAL CENTER B CELLS
    Capote Huelva, F. J.
    Capote Garcia, J.
    Rodrigues Mateos, M. E.
    Martinez Bautista, M. J.
    Moran Sanchez, J.
    Dominguez Lopez, M.
    Santisteban Espejo, A.
    Martin Reina, M., V
    HAEMATOLOGICA, 2017, 102 : 222 - 222
  • [3] Randomized Phase II Study of R-CHOP With or Without Bortezomib in Previously Untreated Patients With Non-Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma
    Leonard, John P.
    Kolibaba, Kathryn S.
    Reeves, James A.
    Tulpule, Anil
    Flinn, Ian W.
    Kolevska, Tatjana
    Robles, Robert
    Flowers, Christopher R.
    Collins, Robert
    DiBella, Nicholas J.
    Papish, Steven W.
    Venugopal, Parameswaran
    Horodner, Andrew
    Tabatabai, Amir
    Hajdenberg, Julio
    Park, Jaehong
    Neuwirth, Rachel
    Mulligan, George
    Suryanarayan, Kaveri
    Esseltine, Dixie-Lee
    de Vos, Sven
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (31) : 3538 - +
  • [4] Frontline treatment of diffuse large B-cell lymphoma: Beyond R-CHOP
    Mondello, Patrizia
    Mian, Michael
    HEMATOLOGICAL ONCOLOGY, 2019, 37 (04) : 333 - 344
  • [5] Phase II trial of split-dose R-CHOP for older patients with diffuse large B-cell lymphoma (DLBCL)
    Shah, Nirav Niranjan
    Szabo, Aniko
    Rajguru, Saurabh
    Devata, Sumana
    Howard, Mitch
    Pereira, Deepa
    Endres, Mariah
    Longo, Walter L.
    Hamadani, Mehdi
    Fenske, Timothy S.
    Fletcher, Christopher David
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [6] Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non-Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study
    Nowakowski, Grzegorz S.
    LaPlant, Betsy
    Macon, William R.
    Reeder, Craig B.
    Foran, James M.
    Nelson, Garth D.
    Thompson, Carrie A.
    Rivera, Candido E.
    Inwards, David J.
    Micallef, Ivana N.
    Johnston, Patrick B.
    Porrata, Luis F.
    Ansell, Stephen M.
    Gascoyne, Randy D.
    Habermann, Thomas M.
    Witzig, Thomas E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03) : 251 - 257
  • [7] Phase III Trial of Subcutaneous Epcoritamab plus R-CHOP Versus R-CHOP Alone in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL): EPCORE DLBCL-2
    Sehn, Laurie
    Chamuleau, Martine
    Lenz, Georg
    Clausen, Michael
    Haioun, Corinne
    Izutsu, Koji
    Davies, Andrew
    Zhu, Jun
    Oki, Toshiko
    Szafer-Glusman, Edith
    Conlon, Rebekah
    Chiou, Hueiyu
    Ipe, David
    Elliott, Brian
    Wu, Jun
    Salles, Gilles
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S440 - S440
  • [8] R-CHOP regimen can significantly decrease the risk of disease relapse and progression in patients with non-germinal center B-cell subtype diffuse large B-cell lymphoma
    He, Xiao-Hui
    Li, Bo
    Yang, Sheng
    Lu, Ning
    Zhang, Xun
    Zou, Shuang-Mei
    Li, Ye-Xiong
    Song, Yong-Wen
    Zheng, Shan
    Dong, Mei
    Zhou, Sheng-Yu
    Yang, Jian-Liang
    Liu, Peng
    Zhang, Chang-Gong
    Qin, Yan
    Feng, Feng-Yi
    Shi, Yuan-Kai
    CHINESE JOURNAL OF CANCER, 2012, 31 (06) : 306 - 314
  • [9] Phase 3 trial of subcutaneous epcoritamab plus R-CHOP versus R-CHOP in patients (pts) with newly diagnosed diffuse large B-cell lymphoma (DLBCL): EPCORE DLBCL-2.
    Sehn, Laurie Helen
    Chamuleau, Martine
    Lenz, Georg
    Clausen, Michael
    Haioun, Corinne
    Izutsu, Koji
    Davies, Andrew John John
    Zhu, Jun
    Oki, Toshiko
    Szafer-Glusman, Edith
    Conlon, Rebekah
    Chiou, Hueiyu
    Ipe, David
    Elliott, Brian
    Wu, Jun
    Salles, Gilles A.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [10] Outcome of R-CHOP or CHOP Regimen for Germinal Center and Nongerminal Center Subtypes of Diffuse Large B-Cell Lymphoma of Chinese Patients
    Huang, Ying
    Ye, Sheng
    Cao, Yabing
    Li, Zhiming
    Huang, Jiajia
    Huang, He
    Cai, Muyan
    Luo, Rongzhen
    Lin, Tongyu
    SCIENTIFIC WORLD JOURNAL, 2012,
12345